Early Surveillance with L-Dex® Reduces Incidence, Severity & Cost of Breast Cancer-Related Lymphedema, ImpediMed Reports Publication in American Cancer Society Journal

BRISBANE, Australia & CARLSBAD, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Lymphedema?src=hash" target="_blank"gt;#Lymphedemalt;/agt;–L-Dex Reduces Incidence, Severity & Cost of Breast Cancer-Related Lymphedema, ImpediMed Reports Publication in American Cancer Society Journal